View of Update on Hedgehog Pathway Inhibitor Therapy for Patients with Basal Cell Naevus Syndrome or High-frequency Basal Cell Carcinoma | Acta Dermato-Venereologica
Cells control energy metabolism via hedgehog signalling pathway | Max-Planck-Gesellschaft
Vismodegib | CAS 879085-55-9 | SCBT - Santa Cruz Biotechnology
Frontiers | The hedgehog pathway in hematopoiesis and hematological malignancy
Cholesterol access in cellular membranes controls Hedgehog signaling | Nature Chemical Biology
Hedgehog signaling inhibitors in solid and hematological cancers
How Erivedge Is Designed To Work | Erivedge® (vismodegib)
Mechanistic Insights into the Generation and Transduction of Hedgehog Signaling: Trends in Biochemical Sciences
Sonic Hedgehog pathway in the pathogenesis of basal cell carcinoma. | Download Scientific Diagram
Switching Hedgehog inhibitors and other strategies to address resistance when treating advanced basal cell carcinoma
Hedgehog signaling, vismodegib action, and acquired resistance | Download Scientific Diagram
Hedgehog pathway inhibition in advanced basal cell carcinoma: latest evidence and clinical usefulness - Sirunya Silapunt, Leon Chen, Michael R. Migden, 2016
Frontiers | Basal Cell Carcinoma and Hedgehog Pathway Inhibitors: Focus on Immune Response
The hedgehog pathway in triple‐negative breast cancer - Habib - 2016 - Cancer Medicine - Wiley Online Library
Erivedge (vismodegib) – Treatment for Advanced Basal Cell Carcinoma - Clinical Trials Arena
The story of vismodegib and basal cell carcinoma
The SHH/GLI signaling pathway: a therapeutic target for medulloblastoma
Vismodegib: a promising drug in the treatment of basal cell carcinomas | Future Oncology
Vismodegib and the Hedgehog Pathway: A New Treatment for Basal Cell Carcinoma - ScienceDirect
IJMS | Free Full-Text | Hedgehog Pathway Inhibitors as Targeted Cancer Therapy and Strategies to Overcome Drug Resistance
Vismodegib | Nature Reviews Drug Discovery
Repurposing itraconazole for the treatment of cancer (Review)
Cells | Free Full-Text | Recent Advances in the Clinical Targeting of Hedgehog/GLI Signaling in Cancer
Vismodegib: A Review - ScienceDirect
IJMS | Free Full-Text | Hedgehog Pathway Inhibitors as Targeted Cancer Therapy and Strategies to Overcome Drug Resistance
Hedgehog Signaling Antagonist GDC-0449 (Vismodegib) Inhibits Pancreatic Cancer Stem Cell Characteristics: Molecular Mechanisms | PLOS ONE
Vismodegib
